About Me

Education: BA, Mount St Mary College, 2003; MD, American University of the Caribbean, 2007
Board Certifications: American Board of Internal Medicine, Critical Care Medicine; American Board of Internal Medicine, Hematology; American Board of Internal Medicine, Internal Medicine; American Board of Pediatrics, Pediatrics
Positions: Assistant Professor, Pulmonary, Critical Care, Allergy, and Immunologic Medicine; Assistant Professor, Hematology and Oncology; Assistant Professor, Anesthesiology
Departments and Affiliations: Pulmonary, Critical Care, Allergy, and Immunologic Medicine; Hematology and Oncology; Anesthesiology

Research

Acute kidney injury is common with intravenous abuse of extended-release oral oxymorphone and delayed renal recovery rates are associated with increased KDIGO staging.. Bonnecaze AK, Wilson MW, Dharod A, Fletcher A, Miller PJ. Nephrology (Carlton). 2018 Oct; 23(10):921-926.
Bilateral exudative retinal detachments due to thrombotic microangiopathy associated with intravenous abuse of Opana ER.. Aseem F, Zamora BG, Kauffman L, Miller PJ, John VJ. Am J Ophthalmol Case Rep. 2018 Sep; 11:72-74.
Correlating S100B with disease course in a case of new onset, acquired thrombotic thrombocytopenic purpura (TTP): Could this be a new predictive biomarker in TTP?. Kuhlman P, Miller P, Farland A, Owen J, Batt K. J Clin Apher. 2018 Aug; 33(4):541-545.
Analysis of Intensive Care Unit Admission and Sequelae in Patients Intravenously Abusing Extended-Release Oral Oxymorphone.. Wilson MW, Bonnecaze AK, Dharod A, Miller PJ. South. Med. J. 2017 03; 110(3):217-222.
A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER.. Hunt R, Yalamanoglu A, Tumlin J, Schiller T, Baek JH, Wu A, Fogo AB, Yang H, Wong E, Miller P, Buehler PW, Kimchi-Sarfaty C. Blood. 2017 02; 129(7):896-905.

View More Publications